Clinical trial
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head &…
NCT00243347 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00243347 |
|---|---|
| Title | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer |
| Official title | An Exploratory, Open-Lael Study to Assess the Effects of AZD2171 on Tumors and Biomarkers in Patients With Previously Untreated or Recurrent Non-small Cell Lung Cancer (NSCLC) or Patients With Metastatic or Recurrent Head and Neck Cancer (HNC) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | AZD2171 |
| Enrollment | 19 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Jul 1, 2009 |
| First posted | Oct 24, 2005 |
| Last update posted | Oct 17, 2013 |
| Countries | Spain, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: